Accumulating evidence has uncovered that CD4+ T cells are critical for the development and progression of chronic intestinal inflammation, and CD4+ T cell-related cytokines (such as TNF-α, IFN-γ, IL-1β, and IL-17) are upregulated in the inflamed mucosa of patients with IBD (28, 29). Here, IL1B is linked to inflammatory bowel disease.